Halma’s (LON:HLMA) Hold Rating Reaffirmed at Shore Capital

Share on StockTwits

Shore Capital reaffirmed their hold rating on shares of Halma (LON:HLMA) in a research report released on Friday, October 19th.

Several other equities analysts also recently weighed in on the company. Jefferies Financial Group reaffirmed a buy rating on shares of Halma in a research note on Wednesday, September 5th. JPMorgan Chase & Co. reaffirmed an underweight rating on shares of Halma in a research note on Thursday, August 23rd. Berenberg Bank reaffirmed a buy rating and issued a GBX 1,570 ($20.51) price objective on shares of Halma in a research note on Thursday, September 6th. Finally, UBS Group reaffirmed a sell rating on shares of Halma in a research note on Friday, September 28th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of GBX 1,346.50 ($17.59).

Shares of HLMA traded down GBX 21 ($0.27) during mid-day trading on Friday, hitting GBX 1,317 ($17.21). The company’s stock had a trading volume of 684,877 shares, compared to its average volume of 921,195. Halma has a 1-year low of GBX 956.50 ($12.50) and a 1-year high of GBX 1,341 ($17.52).

Halma Company Profile

Halma plc provides process and infrastructure safety, medical, and environmental and analysis products worldwide. Its Process Safety segment offers safety systems to control hazardous industrial processes and access to dangerous machines; gas detection instruments; pressure management products; key interlocks and interlocking systems; pipeline corrosion monitoring products and systems; and process safety systems.

Featured Article: Stock Selection – What is cash flow?

Analyst Recommendations for Halma (LON:HLMA)

Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.